Matches in SemOpenAlex for { <https://semopenalex.org/work/W2894519638> ?p ?o ?g. }
- W2894519638 endingPage "1248" @default.
- W2894519638 startingPage "1239" @default.
- W2894519638 abstract "Abstract Purpose Baclofen is widely used off‐label for alcohol use disorders (AUD) in France, despite its uncertain efficacy and safety, particularly at high doses. This study was designed to evaluate the safety of this off‐label use compared to the main approved drugs for AUD (acamprosate, naltrexone, nalmefene). Methods This cohort study from the French Health Insurance claims database included patients, aged 18 to 70 years, with no serious comorbidity (assessed by the Charlson score) initiating baclofen or approved drugs for AUD between 2009 and 2015. The risk of hospitalisation or death associated with baclofen, at variable doses over time (from low doses <30 mg/day to high doses ≥180 mg/day), compared to approved drugs, was evaluated by a Cox model adjusted to sociodemographic and medical characteristics. Results The cohort included 165 334 patients, 47 614 of whom were exposed to baclofen. Patients exposed to baclofen differed from those treated with approved drugs in terms of sociodemographic and medical characteristics (more females, higher socioeconomic status, fewer hospitalisations for alcohol‐related problems), but these differences tended to fade at higher doses of baclofen. Baclofen exposure was significantly associated with hospitalisation (hazard ratio [HR] = 1.13 [95%CI: 1.09‐1.17]) and death (HR = 1.31 [95%CI: 1.08‐1.60]). The risk increased with dose, reaching 1.46 [1.28‐1.65] for hospitalisation and 2.27 [1.27‐4.07] for death at high doses. Similar results were in patients with a history of hospitalisation for alcohol‐related problems. Conclusions This study raises concerns about the safety of baclofen for AUD, particularly at high doses, with higher risks of hospitalisation and mortality than approved drugs." @default.
- W2894519638 created "2018-10-05" @default.
- W2894519638 creator A5020415664 @default.
- W2894519638 creator A5031529875 @default.
- W2894519638 creator A5046017646 @default.
- W2894519638 creator A5059005646 @default.
- W2894519638 creator A5080099253 @default.
- W2894519638 creator A5088948541 @default.
- W2894519638 date "2018-09-25" @default.
- W2894519638 modified "2023-10-16" @default.
- W2894519638 title "Risk of hospitalisation and death related to baclofen for alcohol use disorders: Comparison with nalmefene, acamprosate, and naltrexone in a cohort study of 165 334 patients between 2009 and 2015 in France" @default.
- W2894519638 cites W1418857551 @default.
- W2894519638 cites W1906128922 @default.
- W2894519638 cites W1921920075 @default.
- W2894519638 cites W1982173905 @default.
- W2894519638 cites W2000445173 @default.
- W2894519638 cites W2016722530 @default.
- W2894519638 cites W2021892513 @default.
- W2894519638 cites W2030868346 @default.
- W2894519638 cites W2078594409 @default.
- W2894519638 cites W2102255195 @default.
- W2894519638 cites W2115147032 @default.
- W2894519638 cites W2125995400 @default.
- W2894519638 cites W2136006910 @default.
- W2894519638 cites W2145176659 @default.
- W2894519638 cites W2170979974 @default.
- W2894519638 cites W2172137255 @default.
- W2894519638 cites W2199914463 @default.
- W2894519638 cites W2200958456 @default.
- W2894519638 cites W2274791648 @default.
- W2894519638 cites W2345856256 @default.
- W2894519638 cites W2378098209 @default.
- W2894519638 cites W2552950400 @default.
- W2894519638 cites W2584269700 @default.
- W2894519638 cites W2612744645 @default.
- W2894519638 cites W2615387563 @default.
- W2894519638 cites W2617556060 @default.
- W2894519638 cites W2739302715 @default.
- W2894519638 cites W2741789802 @default.
- W2894519638 cites W2757054309 @default.
- W2894519638 doi "https://doi.org/10.1002/pds.4635" @default.
- W2894519638 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6282718" @default.
- W2894519638 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30251424" @default.
- W2894519638 hasPublicationYear "2018" @default.
- W2894519638 type Work @default.
- W2894519638 sameAs 2894519638 @default.
- W2894519638 citedByCount "31" @default.
- W2894519638 countsByYear W28945196382018 @default.
- W2894519638 countsByYear W28945196382019 @default.
- W2894519638 countsByYear W28945196382020 @default.
- W2894519638 countsByYear W28945196382021 @default.
- W2894519638 countsByYear W28945196382022 @default.
- W2894519638 countsByYear W28945196382023 @default.
- W2894519638 crossrefType "journal-article" @default.
- W2894519638 hasAuthorship W2894519638A5020415664 @default.
- W2894519638 hasAuthorship W2894519638A5031529875 @default.
- W2894519638 hasAuthorship W2894519638A5046017646 @default.
- W2894519638 hasAuthorship W2894519638A5059005646 @default.
- W2894519638 hasAuthorship W2894519638A5080099253 @default.
- W2894519638 hasAuthorship W2894519638A5088948541 @default.
- W2894519638 hasBestOaLocation W28945196381 @default.
- W2894519638 hasConcept C126322002 @default.
- W2894519638 hasConcept C170493617 @default.
- W2894519638 hasConcept C185592680 @default.
- W2894519638 hasConcept C207103383 @default.
- W2894519638 hasConcept C2777972943 @default.
- W2894519638 hasConcept C2778836221 @default.
- W2894519638 hasConcept C2778938600 @default.
- W2894519638 hasConcept C2779442783 @default.
- W2894519638 hasConcept C2779992327 @default.
- W2894519638 hasConcept C2781063702 @default.
- W2894519638 hasConcept C2781066024 @default.
- W2894519638 hasConcept C2781201050 @default.
- W2894519638 hasConcept C44249647 @default.
- W2894519638 hasConcept C55493867 @default.
- W2894519638 hasConcept C71924100 @default.
- W2894519638 hasConcept C72563966 @default.
- W2894519638 hasConceptScore W2894519638C126322002 @default.
- W2894519638 hasConceptScore W2894519638C170493617 @default.
- W2894519638 hasConceptScore W2894519638C185592680 @default.
- W2894519638 hasConceptScore W2894519638C207103383 @default.
- W2894519638 hasConceptScore W2894519638C2777972943 @default.
- W2894519638 hasConceptScore W2894519638C2778836221 @default.
- W2894519638 hasConceptScore W2894519638C2778938600 @default.
- W2894519638 hasConceptScore W2894519638C2779442783 @default.
- W2894519638 hasConceptScore W2894519638C2779992327 @default.
- W2894519638 hasConceptScore W2894519638C2781063702 @default.
- W2894519638 hasConceptScore W2894519638C2781066024 @default.
- W2894519638 hasConceptScore W2894519638C2781201050 @default.
- W2894519638 hasConceptScore W2894519638C44249647 @default.
- W2894519638 hasConceptScore W2894519638C55493867 @default.
- W2894519638 hasConceptScore W2894519638C71924100 @default.
- W2894519638 hasConceptScore W2894519638C72563966 @default.
- W2894519638 hasIssue "11" @default.
- W2894519638 hasLocation W28945196381 @default.
- W2894519638 hasLocation W28945196382 @default.
- W2894519638 hasLocation W28945196383 @default.
- W2894519638 hasOpenAccess W2894519638 @default.